Opportunity Information: Apply for RFA AG 24 033
The State Dementia Care Research Center (U54 Clinical Trial Not Allowed) funding opportunity (RFA-AG-24-033) is a National Institutes of Health cooperative agreement designed to build state-focused research infrastructure that can strengthen how dementia care is coordinated, integrated, and transitioned across community settings. The central goal is to improve real-world care for people living with dementia (PLWD) and to better support their caregivers and care partners by producing practical evidence that health systems, social service providers, and policymakers can use. A major premise of the program is that Alzheimer disease and related dementias (AD/ADRD) care varies widely across the United States because states differ in benefits, coverage rules, delivery systems, workforce capacity, and access to home and community-based services (HCBS). This Center program is meant to take those differences seriously and study them directly, rather than relying on one-size-fits-all national assumptions.
At its core, the Center is expected to do three intertwined things. First, it will support research on how AD/ADRD care coordination, care integration, and care transitions actually work within a state, including movement between settings such as hospitals, primary care, specialty care, home care, adult day programs, nursing facilities, and other community-based supports. This includes identifying gaps and breakdowns that lead to poor outcomes, duplicated services, caregiver burden, avoidable emergency visits, and inequities in access. Second, the Center will build and link data resources that combine information on HCBS and other social services with health care data inside states. This emphasis on data creation and integration reflects a practical need in dementia services research: social services and medical care often live in separate data systems, making it hard to understand the full care pathway and where coordination fails. Third, the Center will actively disseminate findings to stakeholders beyond academia, including providers, community organizations, the public, and state and local policymakers, so that results translate into decision-making and system improvements.
A notable feature of the NOFO is its explicit focus on heterogeneity and disparities. The Center is expected to build a consortium of scholars who can examine differences not just across states, but also within states, recognizing that access and quality can vary sharply by region, rural versus urban settings, income, race and ethnicity, disability status, and other factors tied to structural inequities. The research agenda is framed to advance AD/ADRD implementation milestones related to care integration, with an emphasis on health care disparities and policy relevance. In other words, the program is not simply asking for descriptive studies; it is aiming for an organized research enterprise that can explain how state-level policies, financing mechanisms, delivery models, and local service ecosystems shape dementia care experiences and outcomes.
Administratively, this is a discretionary NIH opportunity using a cooperative agreement (U54) mechanism, which typically means substantial NIH involvement in the direction and oversight of the funded Center compared to a standard research project grant. It is categorized under Health (CFDA 93.866) and is explicitly labeled "Clinical Trial Not Allowed," signaling that applicants should not propose NIH-defined clinical trials as part of the Center activities. The original closing date listed is November 14, 2023, and the award ceiling and expected number of awards are not specified in the provided source information.
Eligibility is broad across public, private, and nonprofit sectors, reflecting the infrastructure and partnership-heavy nature of the work. Eligible applicants include state, county, and local governments; special district governments; public and state-controlled institutions of higher education; private institutions of higher education; independent school districts; federally recognized tribal governments and other tribal organizations; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations other than small businesses; small businesses; and other organizations. The NOFO also highlights additional eligible applicant types such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), as well as faith-based and community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions. At the same time, it clearly restricts foreign involvement: non-U.S. entities (foreign organizations and foreign institutions) are not eligible to apply, non-domestic components of U.S. organizations are not eligible, and foreign components as defined by NIH policy are not allowed.
Overall, the opportunity is best understood as a capacity-building and evidence-generation initiative aimed at making dementia care systems work better at the state level. By supporting rigorous, state-specific research; developing linked social service and health care data assets; and prioritizing dissemination to decision-makers, the Center is intended to produce actionable insights that improve coordination and transitions for PLWD and caregivers while directly addressing disparities driven by uneven service availability, coverage, and access within and across states.Apply for RFA AG 24 033
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "State Dementia Care Research Center (U54 Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
- This funding opportunity was created on 2023-09-06.
- Applicants must submit their applications by 2023-11-14. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs): State Dementia Care Research Center (U54 Clinical Trial Not Allowed) - RFA-AG-24-033
1) What is the State Dementia Care Research Center funding opportunity?
The State Dementia Care Research Center (U54 Clinical Trial Not Allowed) funding opportunity (RFA-AG-24-033) is a National Institutes of Health (NIH) cooperative agreement designed to build state-focused research infrastructure. Its purpose is to strengthen how dementia care is coordinated, integrated, and transitioned across community settings, and to generate practical evidence that stakeholders can use to improve real-world care for people living with dementia (PLWD) and support their caregivers and care partners.
2) What is the main goal of this program?
The central goal is to improve real-world dementia care and caregiver support by producing actionable, state-relevant evidence. The Center is intended to help health systems, social service providers, and policymakers make informed decisions that improve care coordination, care integration, and care transitions across settings.
3) Why is the program focused on states rather than a national approach?
The program is built on the premise that Alzheimer disease and related dementias (AD/ADRD) care varies widely across the United States because states differ in benefits, coverage rules, delivery systems, workforce capacity, and access to home and community-based services (HCBS). Rather than assuming one national model applies everywhere, the Center is expected to study and account for these state-level differences directly.
4) What kinds of dementia care issues is the Center expected to study?
The Center is expected to support research on how AD/ADRD care coordination, care integration, and care transitions actually function within a state. This includes examining movement between settings such as hospitals, primary care, specialty care, home care, adult day programs, nursing facilities, and other community-based supports, and identifying gaps or breakdowns that contribute to poor outcomes, duplicated services, caregiver burden, avoidable emergency visits, and inequities in access.
5) What are the three core activities expected of the Center?
Based on the opportunity description, the Center is expected to do three intertwined things:
- Support research on how dementia care coordination, integration, and transitions work within a state, including identifying where systems fail or fragment.
- Build and link data resources that combine HCBS and other social service information with health care data inside states to better understand full care pathways.
- Actively disseminate findings to stakeholders beyond academia (providers, community organizations, the public, and policymakers) so results translate into decisions and system improvements.
6) What does the opportunity mean by care coordination, care integration, and care transitions?
The opportunity emphasizes how dementia-related services connect and hand off across settings and sectors. Care coordination and integration point to how medical care and social services work together (or fail to), while care transitions focus on what happens when a person moves between settings (for example, hospital to home care, primary care to specialty care, or home to nursing facility) and whether those transitions are smooth, equitable, and supportive for PLWD and caregivers.
7) What settings and services are included in the scope of research?
The description explicitly includes hospitals, primary care, specialty care, home care, adult day programs, nursing facilities, and other community-based supports. The scope also includes HCBS and other social services that impact dementia care experiences and outcomes.
8) Why is data linkage between health care and social services emphasized?
A practical barrier in dementia services research is that social services and medical care often exist in separate data systems. The Center program highlights building and linking data resources to connect HCBS and other social services with health care data within states, enabling a more complete view of care pathways and where coordination breaks down.
9) What kinds of outcomes or system problems is the Center expected to address?
The Center is expected to identify and study gaps and breakdowns that lead to poor outcomes, duplicated services, caregiver burden, avoidable emergency visits, and inequities in access. The intent is to generate evidence that helps improve the functioning of dementia care systems and transitions in real-world contexts.
10) How does the opportunity address disparities and inequities?
The opportunity explicitly focuses on heterogeneity and disparities, recognizing that access and quality can vary sharply within states and across states. The Center is expected to examine differences tied to region, rural versus urban settings, income, race and ethnicity, disability status, and other factors linked to structural inequities, with an emphasis on policy relevance and health care disparities.
11) Does the program expect a consortium or collaborative structure?
Yes. The description states that the Center is expected to build a consortium of scholars who can examine differences across and within states. This reflects an organized research enterprise approach rather than isolated studies.
12) Is the program intended to be descriptive research only?
No. The opportunity states that it is not simply asking for descriptive studies; it is aiming for an organized research enterprise that can explain how state-level policies, financing mechanisms, delivery models, and local service ecosystems shape dementia care experiences and outcomes, with emphasis on implementation milestones related to care integration and policy relevance.
13) What is the funding mechanism and what does U54 mean here?
This opportunity uses a cooperative agreement mechanism (U54). The description notes that cooperative agreements typically involve substantial NIH involvement in the direction and oversight of the funded Center compared to a standard research project grant, reflecting the infrastructure-building and coordinated nature of the work.
14) What does "Clinical Trial Not Allowed" mean for this opportunity?
The funding opportunity is explicitly labeled "Clinical Trial Not Allowed," which signals that applicants should not propose NIH-defined clinical trials as part of the Center activities.
15) Which NIH area and CFDA listing is associated with this opportunity?
The opportunity is categorized under Health and is associated with CFDA 93.866, as described in the provided information.
16) Who is eligible to apply?
Eligibility is broad across public, private, and nonprofit sectors. Eligible applicants include state, county, and local governments; special district governments; public and state-controlled institutions of higher education; private institutions of higher education; independent school districts; federally recognized tribal governments and other tribal organizations; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations other than small businesses; small businesses; and other organizations.
17) Are minority-serving institutions and community-based organizations specifically included as eligible applicants?
Yes. The opportunity highlights additional eligible applicant types including Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs). It also references faith-based and community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions.
18) Are foreign organizations or international components allowed?
No. The opportunity clearly restricts foreign involvement: non-U.S. entities (foreign organizations and foreign institutions) are not eligible to apply, non-domestic components of U.S. organizations are not eligible, and foreign components (as defined by NIH policy) are not allowed.
19) What stakeholders are intended to use the results from the Center?
The Center is expected to disseminate findings beyond academia to providers, community organizations, the public, and state and local policymakers. The program is designed so that evidence produced can be used for decision-making and system improvements.
20) What is the stated application closing date in the provided information?
The original closing date listed in the provided information is November 14, 2023.
21) Is the award ceiling or the expected number of awards provided?
No. The provided information states that the award ceiling and the expected number of awards are not specified in the source information provided.
22) What makes this opportunity a "capacity-building" initiative?
The opportunity is described as capacity-building because it is designed to create and strengthen state-focused research infrastructure, including the development and linkage of data resources and an organized consortium approach, along with active dissemination strategies aimed at real-world system change.
23) How does the program connect research to policy and practice?
The opportunity emphasizes policy relevance and dissemination to decision-makers and stakeholders. It aims to produce practical evidence that health systems, social service providers, and policymakers can use, and it specifically targets understanding how state-level policies, financing mechanisms, delivery models, and service ecosystems shape outcomes and care experiences.
24) What populations are centered in the program's purpose?
The program is centered on people living with dementia (PLWD) and on improving support for their caregivers and care partners. It also highlights the importance of understanding disparities affecting different groups and communities within and across states.
25) What is the overall takeaway of this grant opportunity?
Overall, this NIH cooperative agreement is intended to create a state-focused Center that studies and improves dementia care coordination, integration, and transitions; builds integrated health and social service data resources; and disseminates actionable findings to stakeholders, with an explicit focus on heterogeneity, disparities, and policy relevance in AD/ADRD care systems.
Browse more opportunities from the same category: Health
Next opportunity: Kenya Digital Health Ecosystem Activity
Previous opportunity: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA AG 24 033
Applicants also applied for:
Applicants who have applied for this opportunity (RFA AG 24 033) also looked into and applied for these:
| Funding Opportunity |
|---|
| Approaches to Identifying Preteen Suicide Risk and Protective Factors (R01 Clinical Trial Not Allowed) Apply for RFA MH 24 320 Funding Number: RFA MH 24 320 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: The Harmonized Cognitive Assessment Protocol (HCAP) Network (U24 Clinical Trial Not Allowed) Apply for RFA AG 24 035 Funding Number: RFA AG 24 035 Agency: National Institutes of Health Category: Health Funding Amount: $385,000 |
| Kenya Digital Health Ecosystem Activity Apply for 72061523RFI00001 Funding Number: 72061523RFI00001 Agency: Kenya USAID-Nairobi Category: Health Funding Amount: $20,000,000 |
| Data Coordinating Center for Approaches to Identifying Preteen Suicide Risk and Protective Factors (U24 Clinical Trial Not Allowed) Apply for RFA MH 24 322 Funding Number: RFA MH 24 322 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed) Apply for PAR 23 300 Funding Number: PAR 23 300 Agency: National Institutes of Health Category: Health Funding Amount: $100,000 |
| Computational Models of Influenza Immunity (U01 Clinical Trial Not Allowed) Apply for RFA AI 23 056 Funding Number: RFA AI 23 056 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| Human Virome Program: Characterization of functional interactions between viruses and human and microbial hosts (U01 Clinical Trial Not Allowed) Apply for RFA RM 23 017 Funding Number: RFA RM 23 017 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| Consortium Organization and Data Collaboration Center (CODCC) for the Human Virome Program (HVP) (U24 Clinical Trial Not Allowed) Apply for RFA RM 23 016 Funding Number: RFA RM 23 016 Agency: National Institutes of Health Category: Health Funding Amount: $1,875,000 |
| Human Virome Characterization Centers (U54 Clinical Trial Not Allowed) Apply for RFA RM 23 019 Funding Number: RFA RM 23 019 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Human Virome Program: Developing novel and innovative tools to interrogate and annotate the human virome (U01 Clinical Trial Not Allowed) Apply for RFA RM 23 018 Funding Number: RFA RM 23 018 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| Computationally-Defined Behaviors in Psychiatry (R21 Clinical Trial Optional) Apply for PAR 23 305 Funding Number: PAR 23 305 Agency: National Institutes of Health Category: Health Funding Amount: $275,000 |
| Computational Approaches for Validating Dimensional Constructs of Relevance to Psychopathology (R01 Clinical Trial Optional) Apply for PAR 23 307 Funding Number: PAR 23 307 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Improving Choice, Use, and Equitable Implementation of Biomedical HIV Prevention for Women (R34 Clinical Trial Optional) Apply for RFA MH 24 332 Funding Number: RFA MH 24 332 Agency: National Institutes of Health Category: Health Funding Amount: $450,000 |
| Interventions to Address HIV-Related Comorbidities among Highly Affected Populations Experiencing Health Disparities (R01 - Clinical Trial Required) Apply for RFA MD 24 003 Funding Number: RFA MD 24 003 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed) Apply for PAR 23 301 Funding Number: PAR 23 301 Agency: National Institutes of Health Category: Health Funding Amount: $275,000 |
| Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed) Apply for PAR 23 302 Funding Number: PAR 23 302 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Fc-Dependent Mechanisms of Antibody-Mediated Killing (R01 Clinical Trial Not Allowed) Apply for RFA AI 23 054 Funding Number: RFA AI 23 054 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| NIDCR Award for Sustaining Outstanding Achievement in Research (SOAR) (R35 Clinical Trial Not Allowed) Apply for RFA DE 24 006 Funding Number: RFA DE 24 006 Agency: National Institutes of Health Category: Health Funding Amount: $650,000 |
| Advancing Research Careers (ARC) Institutionally-Focused Research Education Award to Promote Diversity (UE5 - Clinical Trial Not Allowed) Apply for PAR 23 221 Funding Number: PAR 23 221 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed) Apply for PAR 24 037 Funding Number: PAR 24 037 Agency: National Institutes of Health Category: Health Funding Amount: $2,500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA AG 24 033", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
